YPL199C Antibody

What is YPL199C and why are antibodies against it important for research?

YPL199C is a gene designation in Saccharomyces cerevisiae (baker's yeast), with the nomenclature indicating its chromosomal location (P chromosome) and specific open reading frame (199C). Antibodies against the protein encoded by this gene serve as essential tools for detecting, localizing, and studying its function within cellular contexts. These antibodies enable researchers to investigate protein expression levels, post-translational modifications, protein-protein interactions, and subcellular localization through various techniques including western blotting, immunoprecipitation, and immunofluorescence microscopy. The significance of YPL199C antibodies extends to understanding fundamental cellular processes in yeast, which often serve as models for similar processes in higher eukaryotes, including humans. Due to the conserved nature of many yeast proteins, insights gained from YPL199C studies potentially have broader implications for understanding homologous proteins in other organisms.

What are the optimal western blotting conditions for YPL199C antibody?

Successful western blotting with YPL199C antibody requires careful optimization of several parameters. Based on established protocols for similar yeast proteins, recommended conditions include:

Membrane preparation: After protein transfer, membranes should be blocked with Odyssey blocking buffer to reduce non-specific binding . This blocking agent has demonstrated superior performance compared to traditional BSA or milk-based blockers for yeast protein detection.

Antibody dilutions: For primary antibody incubation, a 1:1,000 dilution in Odyssey blocking buffer with incubation for 1 hour at room temperature is recommended . As with other yeast proteins, YPL199C antibody binding benefits from this standardized dilution to achieve optimal signal-to-noise ratio.

Washing protocols: After primary antibody incubation, implement four wash cycles with 1X PBS/0.2% Tween20 for 5 minutes each to remove unbound antibody and reduce background . This washing regimen is critical for achieving clean, interpretable results with minimal background interference.

Secondary antibody selection: Depending on the detection system, use either Goat anti-Rabbit IRDye 800CW (1:10,000) for fluorescent imaging or appropriate HRP-conjugated secondary antibodies for chemiluminescent detection . The membranes should be incubated with secondary antibodies for 30 minutes at room temperature followed by washing as described previously .

Visualization: For optimal band resolution, use a digital imaging system capable of detecting the appropriate wavelength for your secondary antibody. When troubleshooting weak signals, extended exposure times may be required, but care should be taken to avoid overexposure which can obscure specific signals.

How should researchers prepare samples for immunoprecipitation with YPL199C antibody?

Effective immunoprecipitation (IP) with YPL199C antibody requires careful sample preparation to preserve protein interactions while maximizing accessibility of the epitope. The recommended protocol involves:

Cell lysis: Harvest yeast cells during mid-log phase growth and lyse them in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, and protease inhibitor cocktail. Mechanical disruption using glass beads provides optimal lysis of yeast cells while preserving protein integrity and interactions.

Pre-clearing: To reduce non-specific binding, pre-clear the lysate by incubating with Protein A/G beads for 1 hour at 4°C before adding the YPL199C antibody . This step is particularly important for yeast lysates which can exhibit high background binding.

Antibody binding: Incubate the pre-cleared lysate with YPL199C antibody at a ratio of 2-5 μg antibody per 1 mg of total protein overnight at 4°C with gentle rotation . This extended incubation period allows for complete antigen-antibody complex formation.

Bead addition and washing: Add pre-equilibrated Protein A/G beads and incubate for an additional 2-3 hours at 4°C. Perform at least four stringent washes with lysis buffer to remove non-specifically bound proteins while preserving specific interactions .

Elution: Elute the immunoprecipitated complexes by either boiling in SDS-PAGE sample buffer for downstream analysis by western blotting, or use a gentler elution method (such as competitive peptide elution) if the goal is to preserve protein activity or complex integrity for functional studies.

When troubleshooting failed immunoprecipitation experiments, consider adjusting antibody concentration, incubation time, or buffer conditions to optimize antigen-antibody interaction while minimizing non-specific binding.

How can researchers validate the specificity of YPL199C antibody for their experimental system?

Validating antibody specificity is critical for ensuring reliable research outcomes. For YPL199C antibody, a comprehensive validation approach should include:

Genetic controls: Test the antibody on samples from wild-type and YPL199C deletion strains. A specific antibody will show signal in wild-type samples but not in the deletion mutant. This genetic approach represents the gold standard for antibody validation in yeast systems.

Competitive inhibition: Perform competitive binding assays where the antibody is pre-incubated with purified YPL199C protein or an immunizing peptide before application to samples . Progressive reduction in signal with increasing competitor concentration confirms specificity for the target epitope.

Cross-reactivity assessment: Test the antibody against closely related proteins or in heterologous expression systems to evaluate potential cross-reactivity. This is particularly important for antibodies targeting conserved domains.

Multiple detection methods: Validate antibody performance across different techniques (western blotting, immunoprecipitation, immunofluorescence) to ensure consistent specificity across applications. Different techniques expose the antibody to varied epitope conformations and surrounding environments.

Batch consistency testing: When obtaining new antibody lots, perform side-by-side comparisons with previously validated lots to ensure consistent performance and specificity. Western blot analysis can reveal lot-to-lot variations in recognition patterns.

For quantitative validation, researchers should generate a calibration curve using known quantities of purified target protein to establish the linear detection range of the antibody. This approach enables accurate quantification of YPL199C levels in experimental samples and helps identify detection limitations.

What are the considerations for using YPL199C antibody in flow cytometry applications?

Flow cytometry provides valuable information about protein expression at the single-cell level, but applying YPL199C antibody in this context requires specific optimization:

Cell preparation: For intracellular detection of YPL199C, proper fixation and permeabilization are critical. Use 4% paraformaldehyde for fixation (10-15 minutes) followed by permeabilization with 0.1% Triton X-100 or saponin-based buffers that maintain cellular integrity while allowing antibody access .

Antibody titration: Perform antibody titration experiments to determine the optimal concentration that maximizes specific signal while minimizing background. Unlike western blotting where 1:1,000 dilutions are common, flow cytometry may require higher concentrations (1:50-1:200) due to the need for saturation binding .

Controls implementation: Include critical controls for accurate interpretation:

• Unstained cells to establish autofluorescence baseline

• Isotype controls to assess non-specific binding

• Fluorescence Minus One (FMO) controls to set accurate gates when using multiple antibodies

• Positive controls using cells with known high expression of YPL199C

Doublet discrimination: Implement proper doublet discrimination in the analysis to exclude cell aggregates that can lead to false-positive signals . This is achieved by plotting the height versus area or width parameters of a scatter signal.

Dead cell exclusion: Dead cells often exhibit increased autofluorescence and non-specific antibody binding. Include viability dyes in the staining protocol to exclude dead cells from analysis, as they can disproportionately affect results .

Data analysis should include both percentage of positive cells and mean fluorescence intensity (MFI) to fully characterize YPL199C expression. When reporting flow cytometry results, provide complete details of gating strategies and control samples used to establish positive populations .

How can researchers optimize co-immunoprecipitation protocols to study YPL199C protein interactions?

Studying protein-protein interactions involving YPL199C requires optimized co-immunoprecipitation (co-IP) protocols:

Crosslinking considerations: For transient or weak interactions, consider implementing reversible crosslinking using formaldehyde (0.1-1% for 10 minutes) or specialized reagents like DSP (dithiobis[succinimidyl propionate]). This approach stabilizes protein complexes during extraction but allows for reversal during elution and analysis.

Buffer optimization: The composition of the lysis and washing buffers significantly impacts co-IP success. For YPL199C studies, consider testing multiple conditions:

• Standard condition: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40

• Mild condition: 20 mM HEPES pH 7.4, 100 mM NaCl, 0.5% Triton X-100

• Stringent condition: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 1% Triton X-100, 0.1% SDS

The optimal buffer preserves specific interactions while reducing background binding.

Antibody orientation strategies: For complex interactions, consider comparing results from reciprocal co-IPs where each suspected interaction partner is immunoprecipitated in separate experiments . This approach provides stronger evidence for true interactions versus non-specific associations.

Sequential immunoprecipitation can be implemented for studying complex formation, where the eluate from an initial IP is subjected to a second round of IP with an antibody against a different component. This technique helps validate multi-protein complexes containing YPL199C.

Post-IP validation: Beyond western blot analysis of co-precipitated proteins, consider mass spectrometry analysis to identify novel interaction partners . When implementing this approach, include appropriate negative controls and statistical analysis to distinguish true interactions from background contaminants.

How should researchers quantify and normalize western blot data for YPL199C antibody experiments?

Signal quantification: Use digital imaging systems and specialized software that provide linear detection ranges over multiple orders of magnitude. Avoid film-based exposure which often has limited dynamic range. For fluorescent western blots, systems like Odyssey (LI-COR) provide superior quantitative capacity .

Loading control selection: For yeast samples, Phosphoglycerate kinase (Pgk1p) serves as an appropriate loading control due to its stable expression across various growth conditions . Alternative controls include Tub1 (α-tubulin) or Act1 (actin). The selected loading control should be verified for stable expression under your specific experimental conditions.

Normalization procedure: Calculate the ratio of YPL199C signal intensity to loading control signal for each sample using the following approach:

• Measure integrated intensity for both YPL199C and loading control bands

• Subtract local background from each measurement

• Calculate the ratio: (YPL199C intensity - background)/(Loading control intensity - background)

• Compare normalized values across experimental conditions

When comparing multiple blots, include a common reference sample on each blot to enable inter-blot normalization, addressing the issue of blot-to-blot variation in transfer efficiency and detection sensitivity.

Statistical analysis: For western blot quantification, perform at least three biological replicates to enable statistical testing. Present results as mean ± standard deviation or standard error, and apply appropriate statistical tests (t-test for two-group comparisons, ANOVA for multiple groups) to determine significance of observed differences.

What approaches can resolve contradictory results when using YPL199C antibody across different experimental platforms?

Researchers occasionally encounter seemingly contradictory results when using the same YPL199C antibody across different techniques. Resolving these discrepancies requires systematic investigation:

Epitope accessibility analysis: Different experimental conditions expose different protein conformations or epitopes. Consider whether the antibody targets a linear epitope (functional in denatured conditions like western blotting) or a conformational epitope (functional in native conditions like immunoprecipitation) . If necessary, use multiple antibodies targeting different regions of YPL199C to obtain complementary data.

Cross-validation strategies: When discrepancies arise between antibody-based methods, implement orthogonal approaches:

• RNA analysis (qPCR, RNA-seq) to correlate protein data with transcript levels

• Mass spectrometry-based proteomics for antibody-independent protein quantification

• Genetic tagging (GFP, FLAG, etc.) to enable alternative detection methods

Systematic parameter testing: Create a matrix experiment varying key parameters across techniques to identify conditions that produce consistent results:

• Sample preparation methods (native vs. denatured)

• Buffer compositions (salt concentration, detergents, pH)

• Fixation methods (for microscopy or flow cytometry)

• Antibody concentrations and incubation times

Documentation of protocol differences: Maintain detailed records of exactly how each technique was performed, as minor variations in protocol can significantly impact results. This documentation facilitates troubleshooting and enables reproduction of successful approaches.

When reporting contradictory results in publications, transparently discuss the discrepancies and provide detailed methodological information to help readers evaluate the findings and potentially resolve similar issues in their own research.

How can researchers distinguish between specific and non-specific signals when using YPL199C antibody?

Distinguishing genuine YPL199C signals from non-specific background is crucial for accurate data interpretation:

Knockout or knockdown controls: The most definitive approach is comparing signal between wild-type samples and those where YPL199C has been deleted or depleted. True signals will be absent or significantly reduced in knockout/knockdown samples.

Competition assays: Pre-incubate the antibody with increasing concentrations of purified antigen or immunizing peptide before applying to samples . Specific signals will progressively decrease with increasing competitor concentration, while non-specific signals remain unchanged.

Signal pattern analysis: Analyze whether the observed signal pattern matches expectations based on:

• Known molecular weight (check for the presence of specific bands at the expected size)

• Subcellular localization (compare with published localization studies)

• Expression patterns across tissues or conditions (correlate with transcriptomic data)

Antibody dilution series: Specific signals typically maintain their relative intensity across a range of antibody dilutions, while non-specific background may show different dilution characteristics. Performing experiments with an antibody dilution series can help distinguish between these signal types.

Multiple antibody validation: When available, use multiple antibodies targeting different epitopes of YPL199C. Consistent signals across different antibodies provide stronger evidence for specificity.

When presenting data, researchers should clearly indicate how specificity was verified and acknowledge any limitations in distinguishing specific from non-specific signals, particularly in complex experimental systems.

How can YPL199C antibody be used to study post-translational modifications?

Investigating post-translational modifications (PTMs) of YPL199C provides insights into its regulation and function:

Modification-specific antibodies: If available, use antibodies specifically raised against modified forms of YPL199C (phosphorylated, acetylated, ubiquitinated, etc.). These antibodies can detect specific modifications in total cell lysates or following enrichment procedures.

Immunoprecipitation-based approaches: Use YPL199C antibody to immunoprecipitate the protein from cell lysates, then probe the immunoprecipitated material with antibodies against specific modifications . This approach concentrates the protein of interest, enhancing detection sensitivity.

For phosphorylation studies, compare samples treated with and without phosphatase inhibitors during preparation. Additionally, perform phosphatase treatment of immunoprecipitated material as a negative control to confirm phosphorylation-specific signals .

Mass spectrometry analysis: For comprehensive PTM identification, immunoprecipitate YPL199C using validated antibodies, then analyze the purified protein by mass spectrometry. This approach can identify multiple modifications simultaneously and provide site-specific information . The following workflow is recommended:

• Immunoprecipitate YPL199C from scaled-up cultures

• Separate proteins by SDS-PAGE and excise the band corresponding to YPL199C

• Perform in-gel digestion using multiple proteases to maximize sequence coverage

• Analyze peptides by LC-MS/MS with PTM-specific detection methods

• Validate key modifications using targeted approaches

When studying dynamics of modifications, consider time-course experiments combined with specific stimuli or stressors to capture regulatory events affecting YPL199C function.

What are the best practices for using YPL199C antibody in chromatin immunoprecipitation (ChIP) experiments?

Chromatin immunoprecipitation with YPL199C antibody requires specific optimization for successful application:

Crosslinking optimization: For yeast ChIP, standard formaldehyde crosslinking (1% for 10-15 minutes) is typically sufficient, but optimization may be required depending on the specific protein-DNA interaction characteristics. For proteins with weaker DNA associations, consider dual crosslinking with DSG (disuccinimidyl glutarate) followed by formaldehyde.

Sonication parameters: Optimize sonication conditions to generate DNA fragments of 200-500 bp. For yeast samples, this typically requires 10-15 cycles of 30 seconds on/30 seconds off using a standard sonicator. Verify fragmentation efficiency by reverse-crosslinking a sample aliquot and analyzing DNA size distribution by gel electrophoresis.

IP conditions: For ChIP applications, use a higher antibody-to-chromatin ratio than standard IP protocols (typically 5-10 μg antibody per IP reaction). Incubate antibody with chromatin overnight at 4°C with gentle rotation to maximize recovery of specific complexes.

Controls implementation:

• Input control: Save 5-10% of chromatin before IP for normalization

• Mock IP: Perform parallel IP with non-specific IgG from the same species

• Positive control: Include primers for regions known to be bound by YPL199C or related factors

• Negative control: Include primers for regions not expected to be bound

Elution and analysis: After washing, elute protein-DNA complexes and reverse crosslinks according to standard ChIP protocols. For analysis, both targeted (qPCR) and genome-wide (ChIP-seq) approaches can be employed depending on research questions.

For ChIP-seq applications, prepare libraries following standard protocols and include appropriate sequencing controls. During data analysis, compare enriched regions to publicly available datasets for related transcription factors or chromatin regulators to identify potential cooperative or competitive binding relationships.

How can researchers develop and validate a phospho-specific YPL199C antibody for studying its regulation?

Developing phospho-specific antibodies for YPL199C requires understanding its phosphorylation sites and implementing rigorous validation protocols:

Phosphorylation site identification: Prior to antibody development, identify physiologically relevant phosphorylation sites through:

• Bioinformatic prediction using tools like NetPhos or GPS

• Literature review of large-scale phosphoproteomic studies

• Mass spectrometry analysis of purified YPL199C

For antibody development, select sites that are conserved across related species, show dynamic phosphorylation in response to relevant stimuli, or are located in functionally important regions.

Peptide design strategy: Design phosphopeptides (typically 10-15 amino acids) centered on the phosphorylation site of interest. Include the specific phosphorylated residue (often S, T, or Y) and surrounding amino acids that contribute to recognition specificity . For each phosphopeptide, prepare a matching non-phosphorylated version for negative control testing.

Validation methodology: Implement a comprehensive validation strategy including:

• ELISA testing against phospho and non-phospho peptides to confirm specificity

• Western blotting with samples treated with or without phosphatase

• Testing with phosphomimetic mutants (S/T to D/E) versus phospho-null mutants (S/T to A)

• Analysis of samples from cells treated with kinase activators or inhibitors

• Competition assays with phospho and non-phospho peptides

Based on research with other phospho-specific antibodies, particularly those targeting YSPTSPS motifs as discussed in the literature, researchers should pay special attention to potential cross-reactivity with similar phosphorylation motifs . The evidence suggests that antibodies recognizing phosphorylated motifs like YSPTSPS, which shares similarity with YSATLRY and YSPTLFY peptides, might cross-react with similar phosphorylated sequences .

What are the common causes of high background when using YPL199C antibody, and how can they be addressed?

High background is a frequent challenge in antibody-based applications that can obscure specific signals:

Source identification: First, determine the pattern of background to identify likely causes:

• Diffuse background across membrane: Likely inadequate blocking or washing

• Specific bands at incorrect sizes: Potential cross-reactivity or degradation products

• Streaking or smearing: Sample overloading or precipitation during electrophoresis

Protocol optimization strategies:

For western blotting:

• Increase blocking time or concentration (use Odyssey blocking buffer for optimal results)

• Implement more stringent washing protocols (4-5 washes of 5-10 minutes each with PBS/0.2% Tween-20)

• Dilute primary antibody further (test dilutions from 1:500 to 1:5000)

• Reduce secondary antibody concentration (use 1:10,000 to 1:20,000 dilutions)

• Switch to a different membrane type (PVDF often gives lower background than nitrocellulose)

For immunofluorescence:

• Include a permeabilization step optimization (test different detergents and concentrations)

• Add a pre-adsorption step by incubating antibody with yeast lysate from a YPL199C deletion strain

• Include an extra blocking step with normal serum from the secondary antibody species

• Add 0.1-0.3% Triton X-100 to antibody dilution buffers to reduce non-specific binding

For flow cytometry:

• Implement proper doublet discrimination and dead cell exclusion

• Use FMO controls to set accurate gates and identify spillover contribution to background

• Titrate antibody to determine optimal concentration for maximum signal-to-noise ratio

When persistent background issues occur despite these optimizations, consider testing different antibody lots or suppliers, as manufacturing variability can affect specificity and background characteristics.

How should researchers evaluate batch-to-batch variation in YPL199C antibody performance?

Batch-to-batch variation in antibody performance can significantly impact experimental reproducibility:

Standardized testing protocol: Develop a standardized testing protocol that includes:

• Western blot analysis of reference samples with known YPL199C expression levels

• Immunoprecipitation efficiency testing with quantification of pull-down yield

• If applicable, immunofluorescence or flow cytometry on standardized samples

Reference sample preparation: Prepare and aliquot large batches of reference samples that can be used to test multiple antibody lots over time. These samples should include:

• Wild-type yeast with normal YPL199C expression

• YPL199C-overexpressing strains

• YPL199C deletion or knockdown strains as negative controls

• Samples from different experimental conditions relevant to your research

Quantitative assessment: For each new antibody lot, perform quantitative comparison with previous lots:

• Signal intensity at the expected molecular weight

• Signal-to-noise ratio

• Background levels

• Detection limit (minimum amount of protein reliably detected)

• Dynamic range (linear relationship between protein amount and signal intensity)

Documentation system: Maintain detailed records of each lot's performance characteristics, including:

• Lot number and supplier information

• Date of testing and results of standardized assays

• Optimal working dilutions for different applications

• Any unique characteristics or limitations observed

• Reference images of typical results

When substantial variation is detected between lots, adjust protocols accordingly (e.g., dilution factors, incubation times) and communicate these adjustments to all lab members to maintain consistency in ongoing research.

What quality control measures should be implemented when preparing YPL199C antibody for long-term storage and use?

Proper handling and storage of YPL199C antibody preserves its activity and ensures consistent experimental results:

Aliquoting strategy: Upon receiving a new antibody, prepare small single-use aliquots (typically 10-20 μL) to minimize freeze-thaw cycles. Each aliquot should contain sufficient antibody for 1-2 experiments based on typical usage patterns.

Storage conditions optimization:

• Store concentrated antibody stocks at -80°C for long-term preservation

• Keep working aliquots at -20°C for medium-term storage

• For frequently used antibodies, maintain a working aliquot at 4°C with addition of 0.02% sodium azide as preservative (but not exceeding 2-4 weeks of refrigerated storage)

Avoid repeated freeze-thaw cycles, as they can lead to antibody denaturation and loss of activity. Each freeze-thaw cycle can reduce antibody activity by 5-20% depending on formulation and concentration.

Quality control testing schedule:

• Test new antibody immediately upon receipt to establish baseline performance

• Retest after preparation of working aliquots to ensure no activity loss during processing

• Perform periodic testing of stored aliquots (every 6-12 months) to verify retained activity

• Always test refrigerated working solutions before discarding to determine maximum reliable storage time

Activity preservation additives: Consider adding stabilizers to antibody solutions:

• Glycerol (final concentration 30-50%) to prevent freezing-induced denaturation

• Carrier proteins (BSA, 0.1-1%) to prevent adsorption to tube walls

• Protease inhibitors if contamination is a concern

Documentation: Maintain detailed records of antibody procurement, aliquoting, storage conditions, and performance testing to facilitate troubleshooting and ensure experimental reproducibility across multiple studies and researchers.

How can single-chain variable fragment (scFv) derivatives of YPL199C antibody be developed for specialized applications?

Single-chain variable fragments offer advantages over conventional antibodies for certain applications due to their smaller size and engineered properties:

Generation approaches: YPL199C-specific scFvs can be developed through:

• Phage display technology using immunized animals as antibody gene sources

• Cloning and engineering variable regions from existing hybridomas

• Direct selection from synthetic or natural scFv libraries

When using phage display, construct a combinatorial library with sufficient complexity (>10^9 variants) to ensure adequate representation of potential binders . The complexity of the library significantly impacts the probability of isolating high-affinity binders.

Selection and screening: Implement a robust biopanning strategy:

• Immobilize purified YPL199C protein or specific domains

• Incubate with phage-displayed scFv library

• Wash to remove non-specific binders

• Elute specific binders

• Amplify in bacteria

• Repeat for 3-5 rounds with increasing stringency

After selection, screen individual clones by ELISA and sequence promising candidates to identify unique binding molecules.

Affinity maturation: Improve binding characteristics through:

• Error-prone PCR to introduce random mutations

• CDR-focused mutagenesis targeting key binding residues

• DNA shuffling to combine beneficial mutations

Production system selection: For functional scFvs, evaluate expression systems:

• Bacterial systems (E. coli) for simple, high-yield production

• Yeast systems for proper folding and post-translational modifications

• Mammalian cells for complex applications requiring specific modifications

Applications of YPL199C-specific scFvs include:

• Intracellular antibodies (intrabodies) for functional studies

• Fusion proteins with fluorescent or enzymatic reporters

• Building blocks for sophisticated detection reagents

• Components of targeted therapeutic constructs for model systems

Recent advances in monoclonal antibody generation using AI approaches like MAGE (Monoclonal Antibody GEnerator) represent a promising direction for developing novel antibodies without traditional immunization and screening . These sequence-based protein Large Language Models can potentially generate paired variable heavy and light chain antibody sequences that could be engineered into scFvs with desired specificity .

What are the considerations for using YPL199C antibody in multiplexed immunoassays?

Multiplexed detection of YPL199C alongside other proteins offers efficiency and contextual insights:

Antibody compatibility assessment: When designing multiplexed assays, evaluate:

• Species origin of each antibody to avoid cross-reactivity between secondary antibodies

• Potential cross-reactivity between primary antibodies

• Compatible working conditions (buffer composition, pH, detergent concentration)

For fluorescence-based multiplexing, select fluorophores with minimal spectral overlap and match them with the detection capabilities of your imaging system or flow cytometer .

For western blotting: Implement simultaneous detection strategies:

• Use primary antibodies from different species paired with spectrally distinct secondary antibodies

• Employ directly labeled primary antibodies

• Consider sequential probing with intermittent stripping for antibodies with similar characteristics

• Use the LI-COR two-color detection system for simultaneous visualization of multiple targets

For flow cytometry applications:

• Perform antibody titration for each component of the panel individually before combining

• Use FMO controls to accurately set gates and compensation values

• Consider fluorophore brightness when assigning markers to detection channels

• Implement proper live/dead discrimination to prevent false positives

Data analysis approaches: For complex multiplexed datasets:

• Use dimensionality reduction techniques (tSNE, UMAP) for high-parameter data

• Implement clustering algorithms to identify correlated protein expression patterns

• Apply appropriate statistical methods for multiple comparisons

• Consider machine learning approaches for pattern recognition in complex datasets

Quality control for multiplexed assays should include single-stained controls, unstained controls, and samples where individual components are systematically omitted to verify specificity and identify any unexpected interactions between assay components .

How can researchers leverage phospho-specific antibodies to study the YPL199C CTD code?

If YPL199C contains a carboxy-terminal domain (CTD) with phosphorylation sites similar to RNA polymerase II RPB1, specialized approaches can reveal its functional regulation:

CTD code interpretation: Phosphorylation patterns on repeated motifs (such as YSPTSPS in RPB1) constitute a "code" that regulates protein function . For YPL199C, determine if similar regulatory mechanisms exist by mapping phosphorylation patterns across different conditions.

Phospho-specific antibody panel: Develop or obtain antibodies that specifically recognize different phosphorylation states:

• Single phosphorylation at specific residues

• Double or multiple phosphorylations in specific combinations

• Non-phosphorylated forms for baseline comparison

This panel approach enables detailed mapping of dynamic phosphorylation changes .

Functional correlation studies: Connect phosphorylation patterns with functional outcomes through:

• Temporal correlation of phosphorylation changes with protein activity

• Mutation studies replacing phosphorylated residues with phosphomimetic or non-phosphorylatable amino acids

• Pharmacological manipulation of responsible kinases and phosphatases

Phospho-proteomic validation: Complement antibody-based detection with mass spectrometry approaches:

• Immunoprecipitate YPL199C under conditions of interest

• Perform tryptic digestion followed by phosphopeptide enrichment

• Analyze by LC-MS/MS with electron transfer dissociation (ETD) for precise site localization

• Quantify relative abundance of different phosphorylation patterns

Recent research showing that antibodies against phosphorylated YSPTSPS motifs can be found with higher frequency in centenarians suggests potential biological significance of these phosphorylation patterns . The finding that human monoclonal antibodies reactive to peptides YSATLRY and YSPTLFY bound to the phosphorylated YSPTSPS motif indicates structural similarities that may be relevant for YPL199C if it contains similar phosphorylation motifs .